925 Chemokine malfunction: CCL2-nitration mediated dysfunction of T cells in bladder cancer
Main Authors: | Niannian Ji, Neelam Mukherjee, Zhen-Ju Shu, Robert S Svatek, Zaineb Hassouneh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Bladder tumor ILC1s undergo Th17‐like differentiation in human bladder cancer
by: Neelam Mukherjee, et al.
Published: (2021-10-01) -
CHEMOKINES CCL17 AND CCL22 IN SARCOIDOSIS
by: N. M. Lazareva, et al.
Published: (2021-10-01) -
CCL17 and CCL22 chemokines are upregulated in human obesity and play a role in vascular dysfunction
by: Luisa Hueso, et al.
Published: (2023-04-01) -
Elevated CCL2 causes Leydig cell malfunction in metabolic syndrome
by: Qingkui Jiang, et al.
Published: (2020-11-01) -
The chemokine CCL17 is a novel therapeutic target for cardiovascular aging
by: Yang Zhang, et al.
Published: (2023-04-01)